La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System

Identifieur interne : 000C45 ( PascalFrancis/Corpus ); précédent : 000C44; suivant : 000C46

A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System

Auteurs : Alim-Louis Benabid ; Bradley Wallace ; John Mitrofanis ; Rong Xia ; Brigitte Piallat ; Stephan Chabardes ; Francois Berger

Source :

RBID : Pascal:05-0438061

Descripteurs français

English descriptors

Abstract

High-frequency stimulation (HFS) of neural structures has been used since 1997 as an alternative to lesions in functional neurosurgery of movement disorders, and more recently, it has been applied to the treatment of epilepsies, obsessive-compulsive disorders, cluster headaches, and has other applications in experimental models, particularly for obesity. Although their clinical efficacy is not questioned, and that the effects most of the time parallel those of ablative techniques, leading to the concept of functional inhibition, the intimate mechanisms by which HFS induces excitation within fiber bundles and seems to inhibit cellular nuclei is still strongly debated. Principally due to the observation of long-term clinical effects over a period up to 15 years, it is clear that the mechanism is not due to a progressive lesion, as at every moment the interruption of stimulation reverses totally the effects. There is no current proof that long-term HFS is able to reset neural networks, or to induce profound modifications of the functional organization or of the synaptic connectivity. To understand what is responsible for the immediate, reversible and adaptable effects of HFS, several mechanisms must be considered, which might be involved simultaneously or in sequence : i) Jamming of neural transmission through stimulated nuclei is one possibility, based on the principle that the regular imposed activity might drive the neurons to fire in a regular pattern, making it impossible to transmit more subtle messages, either normal or abnormal. Although it is difficult to prove this type of mechanism, it might account for the reports of increased activity following HFS in various structures. ii) Direct inhibition of spike initiation at the level of the membrane could be due to activation of inhibitory terminals, particularly gaba-ergic, or by a blockade of the voltage gated ion channels. iii) Recent data show that HFS decreases the production and release of low molecular weight proteic neurotransmitters, which could account for the functional inhibition while the efferent axon is still excited by the electrical stimulus. iv) Retrograde activation of upstream neuronal structures, as reported in the external pallidum during stimulation of STN, might be responsible of additional jamming-like effects due to collisions with descending spikes. Due to the geometry of the chronic electrodes used in human patients, and to their size as compared to the size of the neural elements, the tentative model of the mechanisms of HFS must take into account possible simultaneous effects of stimulation on the presynaptic, synaptic, axonal, dendritic and post synaptic events, as well as on the fibers "de passage" involved in the vicinity of the stimulating electrodes. To this respect, modeling of the spatial distribution of voltages and currents appears to be of extreme importance. A global model of the mechanism of HFS is proposed. At the level of the somata and cell bodies, spike initiation is profoundly altered leading to a total suppression of spikes, as recorded in pallidal and subthalamic neurons of parkinsonian patients, possibly alterning with intensity driven spike activity, such as reported in STN on brain slices, using intracellular recordings. It seems from these studies that the presynaptic effects are not the determining events.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0300-9009
A02 01      @0 ANUBBR
A03   1    @0 Acta neurol. belg.
A05       @2 105
A06       @2 3
A08 01  1  ENG  @1 A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System
A11 01  1    @1 BENABID (Alim-Louis)
A11 02  1    @1 WALLACE (Bradley)
A11 03  1    @1 MITROFANIS (John)
A11 04  1    @1 XIA (Rong)
A11 05  1    @1 PIALLAT (Brigitte)
A11 06  1    @1 CHABARDES (Stephan)
A11 07  1    @1 BERGER (Francois)
A14 01      @1 INSERM U318, Université Joseph Fourier, CHU Albert Michallon @2 Grenoble @3 FRA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut.
A20       @1 149-157
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 5198A @5 354000131642650050
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 1 p.3/4
A47 01  1    @0 05-0438061
A60       @1 P
A61       @0 A
A64 01  1    @0 Acta neurologica belgica
A66 01      @0 BEL
C01 01    ENG  @0 High-frequency stimulation (HFS) of neural structures has been used since 1997 as an alternative to lesions in functional neurosurgery of movement disorders, and more recently, it has been applied to the treatment of epilepsies, obsessive-compulsive disorders, cluster headaches, and has other applications in experimental models, particularly for obesity. Although their clinical efficacy is not questioned, and that the effects most of the time parallel those of ablative techniques, leading to the concept of functional inhibition, the intimate mechanisms by which HFS induces excitation within fiber bundles and seems to inhibit cellular nuclei is still strongly debated. Principally due to the observation of long-term clinical effects over a period up to 15 years, it is clear that the mechanism is not due to a progressive lesion, as at every moment the interruption of stimulation reverses totally the effects. There is no current proof that long-term HFS is able to reset neural networks, or to induce profound modifications of the functional organization or of the synaptic connectivity. To understand what is responsible for the immediate, reversible and adaptable effects of HFS, several mechanisms must be considered, which might be involved simultaneously or in sequence : i) Jamming of neural transmission through stimulated nuclei is one possibility, based on the principle that the regular imposed activity might drive the neurons to fire in a regular pattern, making it impossible to transmit more subtle messages, either normal or abnormal. Although it is difficult to prove this type of mechanism, it might account for the reports of increased activity following HFS in various structures. ii) Direct inhibition of spike initiation at the level of the membrane could be due to activation of inhibitory terminals, particularly gaba-ergic, or by a blockade of the voltage gated ion channels. iii) Recent data show that HFS decreases the production and release of low molecular weight proteic neurotransmitters, which could account for the functional inhibition while the efferent axon is still excited by the electrical stimulus. iv) Retrograde activation of upstream neuronal structures, as reported in the external pallidum during stimulation of STN, might be responsible of additional jamming-like effects due to collisions with descending spikes. Due to the geometry of the chronic electrodes used in human patients, and to their size as compared to the size of the neural elements, the tentative model of the mechanisms of HFS must take into account possible simultaneous effects of stimulation on the presynaptic, synaptic, axonal, dendritic and post synaptic events, as well as on the fibers "de passage" involved in the vicinity of the stimulating electrodes. To this respect, modeling of the spatial distribution of voltages and currents appears to be of extreme importance. A global model of the mechanism of HFS is proposed. At the level of the somata and cell bodies, spike initiation is profoundly altered leading to a total suppression of spikes, as recorded in pallidal and subthalamic neurons of parkinsonian patients, possibly alterning with intensity driven spike activity, such as reported in STN on brain slices, using intracellular recordings. It seems from these studies that the presynaptic effects are not the determining events.
C02 01  X    @0 002B17
C02 02  X    @0 002B17I
C02 03  X    @0 002B17G
C03 01  X  FRE  @0 Système nerveux pathologie @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Parkinson maladie @5 02
C03 02  X  ENG  @0 Parkinson disease @5 02
C03 02  X  SPA  @0 Parkinson enfermedad @5 02
C03 03  X  FRE  @0 Modèle @5 09
C03 03  X  ENG  @0 Models @5 09
C03 03  X  SPA  @0 Modelo @5 09
C03 04  X  FRE  @0 Mécanisme action @5 10
C03 04  X  ENG  @0 Mechanism of action @5 10
C03 04  X  SPA  @0 Mecanismo acción @5 10
C03 05  X  FRE  @0 Stimulus électrique @5 11
C03 05  X  ENG  @0 Electrical stimulus @5 11
C03 05  X  SPA  @0 Estímulo eléctrico @5 11
C03 06  X  FRE  @0 Système nerveux central @5 12
C03 06  X  ENG  @0 Central nervous system @5 12
C03 06  X  SPA  @0 Sistema nervioso central @5 12
C03 07  X  FRE  @0 Noyau sousthalamique @5 13
C03 07  X  ENG  @0 Subthalamic nucleus @5 13
C03 07  X  SPA  @0 Núcleo subtalámico @5 13
C07 01  X  FRE  @0 Encéphale pathologie @5 37
C07 01  X  ENG  @0 Cerebral disorder @5 37
C07 01  X  SPA  @0 Encéfalo patología @5 37
C07 02  X  FRE  @0 Extrapyramidal syndrome @5 38
C07 02  X  ENG  @0 Extrapyramidal syndrome @5 38
C07 02  X  SPA  @0 Extrapiramidal síndrome @5 38
C07 03  X  FRE  @0 Maladie dégénérative @5 39
C07 03  X  ENG  @0 Degenerative disease @5 39
C07 03  X  SPA  @0 Enfermedad degenerativa @5 39
C07 04  X  FRE  @0 Système nerveux central pathologie @5 40
C07 04  X  ENG  @0 Central nervous system disease @5 40
C07 04  X  SPA  @0 Sistema nervosio central patología @5 40
N21       @1 305
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 05-0438061 INIST
ET : A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System
AU : BENABID (Alim-Louis); WALLACE (Bradley); MITROFANIS (John); XIA (Rong); PIALLAT (Brigitte); CHABARDES (Stephan); BERGER (Francois)
AF : INSERM U318, Université Joseph Fourier, CHU Albert Michallon/Grenoble/France (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 6 aut., 7 aut.)
DT : Publication en série; Niveau analytique
SO : Acta neurologica belgica; ISSN 0300-9009; Coden ANUBBR; Belgique; Da. 2005; Vol. 105; No. 3; Pp. 149-157; Bibl. 1 p.3/4
LA : Anglais
EA : High-frequency stimulation (HFS) of neural structures has been used since 1997 as an alternative to lesions in functional neurosurgery of movement disorders, and more recently, it has been applied to the treatment of epilepsies, obsessive-compulsive disorders, cluster headaches, and has other applications in experimental models, particularly for obesity. Although their clinical efficacy is not questioned, and that the effects most of the time parallel those of ablative techniques, leading to the concept of functional inhibition, the intimate mechanisms by which HFS induces excitation within fiber bundles and seems to inhibit cellular nuclei is still strongly debated. Principally due to the observation of long-term clinical effects over a period up to 15 years, it is clear that the mechanism is not due to a progressive lesion, as at every moment the interruption of stimulation reverses totally the effects. There is no current proof that long-term HFS is able to reset neural networks, or to induce profound modifications of the functional organization or of the synaptic connectivity. To understand what is responsible for the immediate, reversible and adaptable effects of HFS, several mechanisms must be considered, which might be involved simultaneously or in sequence : i) Jamming of neural transmission through stimulated nuclei is one possibility, based on the principle that the regular imposed activity might drive the neurons to fire in a regular pattern, making it impossible to transmit more subtle messages, either normal or abnormal. Although it is difficult to prove this type of mechanism, it might account for the reports of increased activity following HFS in various structures. ii) Direct inhibition of spike initiation at the level of the membrane could be due to activation of inhibitory terminals, particularly gaba-ergic, or by a blockade of the voltage gated ion channels. iii) Recent data show that HFS decreases the production and release of low molecular weight proteic neurotransmitters, which could account for the functional inhibition while the efferent axon is still excited by the electrical stimulus. iv) Retrograde activation of upstream neuronal structures, as reported in the external pallidum during stimulation of STN, might be responsible of additional jamming-like effects due to collisions with descending spikes. Due to the geometry of the chronic electrodes used in human patients, and to their size as compared to the size of the neural elements, the tentative model of the mechanisms of HFS must take into account possible simultaneous effects of stimulation on the presynaptic, synaptic, axonal, dendritic and post synaptic events, as well as on the fibers "de passage" involved in the vicinity of the stimulating electrodes. To this respect, modeling of the spatial distribution of voltages and currents appears to be of extreme importance. A global model of the mechanism of HFS is proposed. At the level of the somata and cell bodies, spike initiation is profoundly altered leading to a total suppression of spikes, as recorded in pallidal and subthalamic neurons of parkinsonian patients, possibly alterning with intensity driven spike activity, such as reported in STN on brain slices, using intracellular recordings. It seems from these studies that the presynaptic effects are not the determining events.
CC : 002B17; 002B17I; 002B17G
FD : Système nerveux pathologie; Parkinson maladie; Modèle; Mécanisme action; Stimulus électrique; Système nerveux central; Noyau sousthalamique
FG : Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie
ED : Nervous system diseases; Parkinson disease; Models; Mechanism of action; Electrical stimulus; Central nervous system; Subthalamic nucleus
EG : Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD : Sistema nervioso patología; Parkinson enfermedad; Modelo; Mecanismo acción; Estímulo eléctrico; Sistema nervioso central; Núcleo subtalámico
LO : INIST-5198A.354000131642650050
ID : 05-0438061

Links to Exploration step

Pascal:05-0438061

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System</title>
<author>
<name sortKey="Benabid, Alim Louis" sort="Benabid, Alim Louis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wallace, Bradley" sort="Wallace, Bradley" uniqKey="Wallace B" first="Bradley" last="Wallace">Bradley Wallace</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mitrofanis, John" sort="Mitrofanis, John" uniqKey="Mitrofanis J" first="John" last="Mitrofanis">John Mitrofanis</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Xia, Rong" sort="Xia, Rong" uniqKey="Xia R" first="Rong" last="Xia">Rong Xia</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Piallat, Brigitte" sort="Piallat, Brigitte" uniqKey="Piallat B" first="Brigitte" last="Piallat">Brigitte Piallat</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chabardes, Stephan" sort="Chabardes, Stephan" uniqKey="Chabardes S" first="Stephan" last="Chabardes">Stephan Chabardes</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Berger, Francois" sort="Berger, Francois" uniqKey="Berger F" first="Francois" last="Berger">Francois Berger</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0438061</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0438061 INIST</idno>
<idno type="RBID">Pascal:05-0438061</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C45</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System</title>
<author>
<name sortKey="Benabid, Alim Louis" sort="Benabid, Alim Louis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wallace, Bradley" sort="Wallace, Bradley" uniqKey="Wallace B" first="Bradley" last="Wallace">Bradley Wallace</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mitrofanis, John" sort="Mitrofanis, John" uniqKey="Mitrofanis J" first="John" last="Mitrofanis">John Mitrofanis</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Xia, Rong" sort="Xia, Rong" uniqKey="Xia R" first="Rong" last="Xia">Rong Xia</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Piallat, Brigitte" sort="Piallat, Brigitte" uniqKey="Piallat B" first="Brigitte" last="Piallat">Brigitte Piallat</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chabardes, Stephan" sort="Chabardes, Stephan" uniqKey="Chabardes S" first="Stephan" last="Chabardes">Stephan Chabardes</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Berger, Francois" sort="Berger, Francois" uniqKey="Berger F" first="Francois" last="Berger">Francois Berger</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Acta neurologica belgica</title>
<title level="j" type="abbreviated">Acta neurol. belg.</title>
<idno type="ISSN">0300-9009</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Acta neurologica belgica</title>
<title level="j" type="abbreviated">Acta neurol. belg.</title>
<idno type="ISSN">0300-9009</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Central nervous system</term>
<term>Electrical stimulus</term>
<term>Mechanism of action</term>
<term>Models</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Subthalamic nucleus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Parkinson maladie</term>
<term>Modèle</term>
<term>Mécanisme action</term>
<term>Stimulus électrique</term>
<term>Système nerveux central</term>
<term>Noyau sousthalamique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">High-frequency stimulation (HFS) of neural structures has been used since 1997 as an alternative to lesions in functional neurosurgery of movement disorders, and more recently, it has been applied to the treatment of epilepsies, obsessive-compulsive disorders, cluster headaches, and has other applications in experimental models, particularly for obesity. Although their clinical efficacy is not questioned, and that the effects most of the time parallel those of ablative techniques, leading to the concept of functional inhibition, the intimate mechanisms by which HFS induces excitation within fiber bundles and seems to inhibit cellular nuclei is still strongly debated. Principally due to the observation of long-term clinical effects over a period up to 15 years, it is clear that the mechanism is not due to a progressive lesion, as at every moment the interruption of stimulation reverses totally the effects. There is no current proof that long-term HFS is able to reset neural networks, or to induce profound modifications of the functional organization or of the synaptic connectivity. To understand what is responsible for the immediate, reversible and adaptable effects of HFS, several mechanisms must be considered, which might be involved simultaneously or in sequence : i) Jamming of neural transmission through stimulated nuclei is one possibility, based on the principle that the regular imposed activity might drive the neurons to fire in a regular pattern, making it impossible to transmit more subtle messages, either normal or abnormal. Although it is difficult to prove this type of mechanism, it might account for the reports of increased activity following HFS in various structures. ii) Direct inhibition of spike initiation at the level of the membrane could be due to activation of inhibitory terminals, particularly gaba-ergic, or by a blockade of the voltage gated ion channels. iii) Recent data show that HFS decreases the production and release of low molecular weight proteic neurotransmitters, which could account for the functional inhibition while the efferent axon is still excited by the electrical stimulus. iv) Retrograde activation of upstream neuronal structures, as reported in the external pallidum during stimulation of STN, might be responsible of additional jamming-like effects due to collisions with descending spikes. Due to the geometry of the chronic electrodes used in human patients, and to their size as compared to the size of the neural elements, the tentative model of the mechanisms of HFS must take into account possible simultaneous effects of stimulation on the presynaptic, synaptic, axonal, dendritic and post synaptic events, as well as on the fibers "de passage" involved in the vicinity of the stimulating electrodes. To this respect, modeling of the spatial distribution of voltages and currents appears to be of extreme importance. A global model of the mechanism of HFS is proposed. At the level of the somata and cell bodies, spike initiation is profoundly altered leading to a total suppression of spikes, as recorded in pallidal and subthalamic neurons of parkinsonian patients, possibly alterning with intensity driven spike activity, such as reported in STN on brain slices, using intracellular recordings. It seems from these studies that the presynaptic effects are not the determining events.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0300-9009</s0>
</fA01>
<fA02 i1="01">
<s0>ANUBBR</s0>
</fA02>
<fA03 i2="1">
<s0>Acta neurol. belg.</s0>
</fA03>
<fA05>
<s2>105</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>BENABID (Alim-Louis)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>WALLACE (Bradley)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MITROFANIS (John)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>XIA (Rong)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>PIALLAT (Brigitte)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>CHABARDES (Stephan)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BERGER (Francois)</s1>
</fA11>
<fA14 i1="01">
<s1>INSERM U318, Université Joseph Fourier, CHU Albert Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>149-157</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>5198A</s2>
<s5>354000131642650050</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.3/4</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0438061</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Acta neurologica belgica</s0>
</fA64>
<fA66 i1="01">
<s0>BEL</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>High-frequency stimulation (HFS) of neural structures has been used since 1997 as an alternative to lesions in functional neurosurgery of movement disorders, and more recently, it has been applied to the treatment of epilepsies, obsessive-compulsive disorders, cluster headaches, and has other applications in experimental models, particularly for obesity. Although their clinical efficacy is not questioned, and that the effects most of the time parallel those of ablative techniques, leading to the concept of functional inhibition, the intimate mechanisms by which HFS induces excitation within fiber bundles and seems to inhibit cellular nuclei is still strongly debated. Principally due to the observation of long-term clinical effects over a period up to 15 years, it is clear that the mechanism is not due to a progressive lesion, as at every moment the interruption of stimulation reverses totally the effects. There is no current proof that long-term HFS is able to reset neural networks, or to induce profound modifications of the functional organization or of the synaptic connectivity. To understand what is responsible for the immediate, reversible and adaptable effects of HFS, several mechanisms must be considered, which might be involved simultaneously or in sequence : i) Jamming of neural transmission through stimulated nuclei is one possibility, based on the principle that the regular imposed activity might drive the neurons to fire in a regular pattern, making it impossible to transmit more subtle messages, either normal or abnormal. Although it is difficult to prove this type of mechanism, it might account for the reports of increased activity following HFS in various structures. ii) Direct inhibition of spike initiation at the level of the membrane could be due to activation of inhibitory terminals, particularly gaba-ergic, or by a blockade of the voltage gated ion channels. iii) Recent data show that HFS decreases the production and release of low molecular weight proteic neurotransmitters, which could account for the functional inhibition while the efferent axon is still excited by the electrical stimulus. iv) Retrograde activation of upstream neuronal structures, as reported in the external pallidum during stimulation of STN, might be responsible of additional jamming-like effects due to collisions with descending spikes. Due to the geometry of the chronic electrodes used in human patients, and to their size as compared to the size of the neural elements, the tentative model of the mechanisms of HFS must take into account possible simultaneous effects of stimulation on the presynaptic, synaptic, axonal, dendritic and post synaptic events, as well as on the fibers "de passage" involved in the vicinity of the stimulating electrodes. To this respect, modeling of the spatial distribution of voltages and currents appears to be of extreme importance. A global model of the mechanism of HFS is proposed. At the level of the somata and cell bodies, spike initiation is profoundly altered leading to a total suppression of spikes, as recorded in pallidal and subthalamic neurons of parkinsonian patients, possibly alterning with intensity driven spike activity, such as reported in STN on brain slices, using intracellular recordings. It seems from these studies that the presynaptic effects are not the determining events.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17I</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Modèle</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Models</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Modelo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Mécanisme action</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Mechanism of action</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Mecanismo acción</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Stimulus électrique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Electrical stimulus</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Estímulo eléctrico</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Système nerveux central</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Central nervous system</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Sistema nervioso central</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Noyau sousthalamique</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Subthalamic nucleus</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Núcleo subtalámico</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>305</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 05-0438061 INIST</NO>
<ET>A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System</ET>
<AU>BENABID (Alim-Louis); WALLACE (Bradley); MITROFANIS (John); XIA (Rong); PIALLAT (Brigitte); CHABARDES (Stephan); BERGER (Francois)</AU>
<AF>INSERM U318, Université Joseph Fourier, CHU Albert Michallon/Grenoble/France (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 6 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Acta neurologica belgica; ISSN 0300-9009; Coden ANUBBR; Belgique; Da. 2005; Vol. 105; No. 3; Pp. 149-157; Bibl. 1 p.3/4</SO>
<LA>Anglais</LA>
<EA>High-frequency stimulation (HFS) of neural structures has been used since 1997 as an alternative to lesions in functional neurosurgery of movement disorders, and more recently, it has been applied to the treatment of epilepsies, obsessive-compulsive disorders, cluster headaches, and has other applications in experimental models, particularly for obesity. Although their clinical efficacy is not questioned, and that the effects most of the time parallel those of ablative techniques, leading to the concept of functional inhibition, the intimate mechanisms by which HFS induces excitation within fiber bundles and seems to inhibit cellular nuclei is still strongly debated. Principally due to the observation of long-term clinical effects over a period up to 15 years, it is clear that the mechanism is not due to a progressive lesion, as at every moment the interruption of stimulation reverses totally the effects. There is no current proof that long-term HFS is able to reset neural networks, or to induce profound modifications of the functional organization or of the synaptic connectivity. To understand what is responsible for the immediate, reversible and adaptable effects of HFS, several mechanisms must be considered, which might be involved simultaneously or in sequence : i) Jamming of neural transmission through stimulated nuclei is one possibility, based on the principle that the regular imposed activity might drive the neurons to fire in a regular pattern, making it impossible to transmit more subtle messages, either normal or abnormal. Although it is difficult to prove this type of mechanism, it might account for the reports of increased activity following HFS in various structures. ii) Direct inhibition of spike initiation at the level of the membrane could be due to activation of inhibitory terminals, particularly gaba-ergic, or by a blockade of the voltage gated ion channels. iii) Recent data show that HFS decreases the production and release of low molecular weight proteic neurotransmitters, which could account for the functional inhibition while the efferent axon is still excited by the electrical stimulus. iv) Retrograde activation of upstream neuronal structures, as reported in the external pallidum during stimulation of STN, might be responsible of additional jamming-like effects due to collisions with descending spikes. Due to the geometry of the chronic electrodes used in human patients, and to their size as compared to the size of the neural elements, the tentative model of the mechanisms of HFS must take into account possible simultaneous effects of stimulation on the presynaptic, synaptic, axonal, dendritic and post synaptic events, as well as on the fibers "de passage" involved in the vicinity of the stimulating electrodes. To this respect, modeling of the spatial distribution of voltages and currents appears to be of extreme importance. A global model of the mechanism of HFS is proposed. At the level of the somata and cell bodies, spike initiation is profoundly altered leading to a total suppression of spikes, as recorded in pallidal and subthalamic neurons of parkinsonian patients, possibly alterning with intensity driven spike activity, such as reported in STN on brain slices, using intracellular recordings. It seems from these studies that the presynaptic effects are not the determining events.</EA>
<CC>002B17; 002B17I; 002B17G</CC>
<FD>Système nerveux pathologie; Parkinson maladie; Modèle; Mécanisme action; Stimulus électrique; Système nerveux central; Noyau sousthalamique</FD>
<FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie</FG>
<ED>Nervous system diseases; Parkinson disease; Models; Mechanism of action; Electrical stimulus; Central nervous system; Subthalamic nucleus</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Parkinson enfermedad; Modelo; Mecanismo acción; Estímulo eléctrico; Sistema nervioso central; Núcleo subtalámico</SD>
<LO>INIST-5198A.354000131642650050</LO>
<ID>05-0438061</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C45 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000C45 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0438061
   |texte=   A putative generalized model of the effects and mechanism of action of High Frequency Electrical Stimulation of the Central Nervous System
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024